Softgels are a popular dosage form among consumers because of their easy swallowability and quick onset of action. Pharmaceutical developers often don’t consider softgels to be the best choice for prescription drug formulations, however, instead favoring tablets and hard-shell capsules. The disconnect between consumer and formulator preferences for prescription drugs may be due in part to misconceptions surrounding the development process for softgels and their perceived limitations.
Here, we explore seven myths about softgel formulation for prescription drugs and why this dosage form is more viable than formulators may assume. Download the article to learn more.